Investigation of cell mediated immune response induced by varicella vaccine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080223477

Enrollment

Registered

2017-03-10

Start date

2017-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of herpes zoster

Interventions

investigational material(s) Generic name etc : Oka/Biken live attenuated varicella zoster vaccine INN of investigational material : Freeze-dried Live Attenuated Varicella Vaccine (BIKEN) Therapeutic

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Varicella vaccine applicants

Exclusion criteria

Exclusion criteria: History of Herpes Zoster Confirmed history of immunodeficiency disease

Design outcomes

Primary

Measure	Time frame
exploratory Correlation between varicella vaccination and VZV specific T-cells count	—

Secondary

Measure	Time frame
confirmatory Confirming the state of VZV specific antibody using EIA	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026